PAHC
Phibro Animal Health Corporation
Drug Manufacturers - Specialty & Generic · Healthcare · United States
34.06
close · 2026-08-13
value
78
cheaper than peers78
quality
75
stronger fundamentals75
ranked against
Drug Manufacturers - Specialty & Generic
value
quality
34 peerswide variation
Value inputs
| measure | company | vs peers |
| price to sales | 0.98× | 95 |
| forward P/E | 10.19× | 69 |
| EV to EBITDA | 9.32× | 67 |
| price to book | 3.82× | 53 |
4 of 12 measures available
Quality inputs
| measure | company | vs peers |
| return on equity | 30.3% | 91 |
| operating margin | 12.6% | 66 |
| revenue growth | 10.3% | 64 |
| debt to equity | 218.0% | 29 |
4 of 4 measures available
Facts
| market cap | $1B |
| free cash flow | -$17.7M |
| employees | 2,475 |
| first trade | 2014-04-11 |
| next earnings | not reported |
| fundamentals updated | 2026-07-31 |